Liposomes have been featured in the scientific literature for decades. They are mentioned at conferences, appear in technical data sheets, and are touted as the star ingredient in the marketing of hundreds of products. However, the reality in most cosmetic formulation laboratories in Latin America is quite different: they are used incorrectly, used infrequently, or not used at all.
The problem isn't the technology; it's the lack of technical understanding of what they really are, how they work, and, above all, when it makes sense to incorporate them into a formulation. This guide bridges that gap.
What Is a Liposome?—Without Misleading Simplifications
A liposome is a nanoscale spherical vesicle, typically between 50 and 500 nanometers in diameter, formed by one or more concentric bilayers of phospholipids. The phospholipids most commonly used in cosmetics are derived from soy lecithin, although the quality and purity of that lecithin largely determine the effectiveness of the resulting liposome. Working with purified, cosmetic-grade phospholipids is not the same as working with unfractionated, raw lecithin.
The structure of the liposome is fundamentally biomimetic: it replicates the architecture of human cell membranes. This has enormous practical implications for formulation. First, the skin does not identify the liposome as a foreign agent; it recognizes it as structurally compatible. Second, this structure allows for the simultaneous encapsulation of hydrophilic active ingredients in the aqueous core and lipophilic active ingredients within the lipid bilayer. A single delivery system for two distinct chemical classes.
The problem they solve: bioavailability
The central challenge of any active cosmetic formulation is not having good ingredients, but ensuring that those ingredients reach the area where they need to act. The human epidermis evolved specifically to prevent the penetration of external substances. The stratum corneum, the outermost layer, functions as a highly efficient lipid barrier. The vast majority of cosmetic active ingredients applied in their free form get trapped in that barrier or degrade before reaching the viable layers of the epidermis.
Liposomes solve this problem through a mechanism that biophysics describes as membrane fusion. Upon coming into contact with the lipids of the stratum corneum, the liposome’s bilayer fuses with the skin barrier and gradually releases its contents into the deeper layers. It does not force penetration; rather, it facilitates it at the molecular level.
The literature reports increases in bioavailability of up to tenfold compared to the free form of the same active ingredient, as measured using in vitro fluorescence and penetration techniques. This effect is quantified in the laboratory; it is not a claim made on the label.
The Four Benefits Every Formulator Should Understand
- Protection of sensitive active ingredients. Ingredients such as retinol, ascorbic acid (vitamin C), and certain peptides are notoriously unstable. Liposomal encapsulation isolates them from the surrounding environment until they are released. Your most valuable active ingredient reaches the skin intact, not partially degraded in the container.
- Controlled release. Instead of a spike in concentration followed by a rapid drop, the liposome releases the active ingredient steadily over several hours. An encapsulated retinol at 0.3% can deliver results comparable to free retinol at higher concentrations, with a fraction of the skin sensitization.
- Enhanced sensory experience. Well-formulated liposomes improve the sensory profile of active ingredients that would otherwise be difficult to incorporate. Heavy oils feel lighter, strongly scented active ingredients are masked, and the texture of the final emulsion becomes more refined.
- Formulation Compatibility. Certain active ingredients are difficult to stabilize in conventional emulsions due to pH, solubility, or interactions with other ingredients. Encapsulation creates a protected microenvironment that allows otherwise incompatible active ingredients to be combined in the same formulation.
When NOT to encapsulate
Not all active ingredients require liposomes, and not all formulations benefit from encapsulation. If your active ingredient already penetrates the skin well in its free form, if its target is the surface of the stratum corneum, or if stability isn’t an issue in your formulation base, incorporating liposomes may add cost without any measurable benefit. Encapsulation is a precision tool, not a technical gimmick for the label.
A good liposomal technology provider should be able to help you determine whether your active ingredient would benefit from encapsulation before you begin any development. If someone tells you that everything needs liposomes, be wary.
What Sets a High-Quality Liposome Apart from a Mediocre One
The difference between a liposome that works and one that doesn't is rarely apparent in the product data sheet. These are the parameters every formulator should require from their supplier:
- Documented particle size, including distribution—not just an average. A D90 of 200 nm is not the same as a D50 of 200 nm with a distribution tail extending up to 800 nm.
- Encapsulation efficiency: what percentage of the active ingredient is actually inside the liposome. A real number, not an estimate.
- Accelerated stability testing: data at 40°C/75% RH for at least 3 months. If your supplier doesn't have this data, they probably didn't perform the test.
- Certificate of analysis by batch, not by product line. Each batch is a separate production run and must be documented as such.
An Opportunity for the Regional Industry
For years, liposomal encapsulation has been a technology dominated by European and North American suppliers, with import costs and lead times that made it accessible only to large corporations. That is changing.
Today, there are direct channels for accessing world-class liposomal technology for laboratories of any size in the region, along with the technical guidance that makes the difference between simply purchasing an ingredient and solving a formulation problem. Access is no longer the barrier. Now, the challenge is knowing what to order.